Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease
International Journal of Molecular Sciences
March 2026
Muriel P.
Open Access
β-Alanine alleviated non-alcoholic fatty liver disease via regulation of hepatic sulfur-amino acid metabolism in mice
Toxicological Research
January 2026
Lee J.
All Open Access, Green
High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis
World Journal of Hepatology
January 2026
Zhang Z.R.
Open Access
N-acetylcysteine reduces the hepatic complications of social isolation stress through modulation of interleukin 1 and 6 gene expression and liver enzymes in mice
Scientific Reports
December 2025
Asgharzadeh J.
Open Access
Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: a randomized controlled study
Diabetology and Metabolic Syndrome
December 2025
Emara S.M.
Open Access
Optimized Protocol for Primary Rat Hepatocyte Isolation and a Model for Investigating Experimental Steatosis
Methods and Protocols
October 2025
Harb A.A.
Open Access
New Approach Combination-Dosed Therapy for Nonalcoholic Steatohepatitis Versus Vitamin E: A Randomized Controlled Trial
Clinical Therapeutics
August 2025
Zakaria A.Y.
Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A
Biochemical and Biophysical Research Communications
22 July 2025
Ko J.H.
A Comparative Study of N-Acetyl Cysteine, Rosuvastatin, and Vitamin E in the Management of Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Trial
Pharmaceuticals
May 2025
Zakaria A.Y.
Open Access
Liver ischemia reperfusion injury: Mechanisms, cellular pathways, and therapeutic approaches
International Immunopharmacology
26 March 2025
de Oliveira T.H.C.
Open Access
A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment
Naunyn Schmiedeberg S Archives of Pharmacology
March 2025
Galicia-Moreno M.
Efficacy of N-Acetylcysteine on Liver Function and Metabolic Profiles in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Double-Blind, Randomized Controlled Trial
Addiction and Health
2025
Sinaeinejad M.
Open Access
Vitamin E for people with non-alcoholic fatty liver disease
Cochrane Database of Systematic Reviews
16 October 2024
Wen H.
All Open Access, Green
Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications
Human Nutrition and Metabolism
September 2024
Lewis Lujan L.M.
Open Access
Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
Materials and Design
March 2024
Carmignani A.
Open Access
A Multidrug Donor Preconditioning Improves Steatotic Rat Liver Allograft Function and Recipient Survival After Transplantation
Transplant International
2024
Xu M.
Open Access
N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals
Antioxidants
October 2023
Tieu S.
Open Access
Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease
Biochemical and Biophysical Research Communications
10 September 2023
Han Y.H.
Open Access
N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial
Alcohol and Alcoholism
1 September 2023
Morley K.C.
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
International Journal of Molecular Sciences
July 2023
Alonso-Peña M.
Open Access
The efficacy of N-acetylcysteine in improving liver function: A systematic review and meta-analysis of controlled clinical trials
Pharmanutrition
June 2023
Nikbaf-Shandiz M.
Long non-coding RNA-EN_181 potentially contributes to the protective effects of N-acetylcysteine against non-alcoholic fatty liver disease in mice
British Journal of Nutrition
28 March 2023
Pi A.